Drug Manufacturers—Specialty & Generic Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 349 |  HLN Haleon plc American Depositary Shares (Each representing two Or | 9.84 USD | +1.23% | +4.79% | +9.82% | -2.48% | 44.05 B USD | ||
| 374 |  TEVA Teva Pharmaceutical Industries Limited American Depositary Shar | 34.63 USD | -1.87% | +2.12% | +3.59% | +81.21% | 40.32 B USD | ||
| 432 |  ZTS Zoetis Inc. Class A Common Stock | 76.29 USD | +1.17% | +5.46% | -4.22% | -47.86% | 31.98 B USD | ||
| 498 |  TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.97 USD | +0.41% | +6.46% | +8.57% | +19.59% | 26.44 B USD | ||
| 602 |  VTRS Viatris Inc. - Common Stock | 16.96 USD | +0.95% | +5.80% | +5.15% | +63.86% | 19.75 B USD | ||
| 631 |  NBIX Neurocrine Biosciences, Inc. - Common Stock | 177.49 USD | +1.95% | +5.18% | +7.64% | +22.41% | 17.85 B USD | ||
| 804 |  ELAN Elanco Animal Health Incorporated Common Stock | 24.66 USD | -1.83% | +0.90% | +2.45% | +10.14% | 12.32 B USD | ||
| 811 |  RDY Dr. Reddy's Laboratories Ltd | 14.65 USD | +2.02% | +2.30% | +10.23% | -1.08% | 12.23 B USD | ||
| 967 |  ALKS Alkermes plc - Ordinary Shares | 55.22 USD | +0.15% | +5.52% | +27.44% | +86.18% | 9.20 B USD | ||
| 1137 |  LNTH Lantheus Holdings, Inc. - Common Stock | 103.41 USD | +0.57% | -7.41% | +2.47% | +84.46% | 6.73 B USD | ||
| 1295 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.05 USD | +0.77% | -1.56% | +22.66% | +61.61% | 5.44 B USD | ||
| 1349 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 40.83 USD | +2.10% | -1.09% | +7.59% | +21.52% | 4.98 B USD | ||
| 1722 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.95 USD | +6.06% | -1.16% | -72.13% | -69.52% | 2.94 B USD | ||
| 1780 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.94 USD | +1.48% | +2.04% | +6.87% | -11.22% | 2.78 B USD | ||
| 1882 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 50.42 USD | +3.17% | +4.80% | +4.69% | -35.95% | 2.39 B USD | ||
| 2019 |  ANIP ANI Pharmaceuticals, Inc. - Common Stock | 85.99 USD | +1.11% | +3.04% | +6.10% | -9.13% | 1.96 B USD | ||
| 2032 |  HCM HUTCHMED (China) Limited - American Depositary Shares | 11.08 USD | -4.89% | +1.65% | +1.84% | -30.75% | 1.93 B USD | ||
| 2062 |  BHC Bausch Health Companies Inc. Common Stock | 4.92 USD | +2.50% | +0.20% | -5.02% | -27.54% | 1.84 B USD | ||
| 2111 |  HROW Harrow, Inc. - Common Stock | 46.15 USD | +2.72% | +6.39% | +37.35% | +18.33% | 1.72 B USD | ||
| 2182 |  PRGO Perrigo Company plc Ordinary Shares | 11.20 USD | +0.99% | +7.07% | +1.91% | -47.96% | 1.55 B USD |
Nouvelles Drug Manufacturers—Specialty & Generic Stocks
PRF Technologies finalise la phase de validation de sa plateforme IA pour l’énergie
Opaleye Management vend pour 4,77 M$ d’actions Eton Pharmaceuticals (ETON)
Teva présente des premières données sur la repigmentation précoce de la peau, prépare le terrain pour la prochaine étude | Benzinga France
Le titre d’Eton Pharmaceuticals atteint un sommet historique à 38,6 USD
Teva fait progresser son anticorps anti-IL-15 en Phase 2b pour le vitiligo
60% de réduction sur InvestingPro : le prix le plus bas de 2026 pour une durée limitée
Le SVP et CFO d’Ani Pharmaceuticals vend des actions pour 284 000 $
Gainers Drug Manufacturers—Specialty & Generic Stocks
Losers Drug Manufacturers—Specialty & Generic Stocks
 BFRIW Biofrontera Inc. - Warrants | 0.0287 | -18.00% |
 BGM BGM Group Ltd. - Class A Ordinary Shares | 0.33 | -13.16% |
 CPHI China Pharma Holdings, Inc. Common Stock | 0.66 | -7.04% |
 IXHL Incannex Healthcare Inc. - Common Stock | 3.71 | -7.02% |
 SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock | 3.26 | -6.86% |
 DERM Journey Medical Corporation - Common Stock | 6.74 | -6.65% |
 AKAN Akanda Corp. - Common Shares | 11.42 | -5.70% |
 CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.01 | -5.61% |